249 related articles for article (PubMed ID: 27703092)
1. Survival Outcomes for Combined Modality Therapy for Sinonasal Undifferentiated Carcinoma.
Kuo P; Manes RP; Schwam ZG; Judson BL
Otolaryngol Head Neck Surg; 2017 Jan; 156(1):132-136. PubMed ID: 27703092
[TBL] [Abstract][Full Text] [Related]
2. Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): The Mayo Clinic Experience.
Gamez ME; Lal D; Halyard MY; Wong WW; Vargas C; Ma D; Ko SJ; Foote RL; Patel SH
Head Neck; 2017 Sep; 39(9):1819-1824. PubMed ID: 28561906
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes and prognostic factors, including human papillomavirus, for sinonasal undifferentiated carcinoma: a retrospective review.
Gray ST; Herr MW; Sethi RK; Diercks G; Lee L; Curry W; Chan A; Clark J; Holbrook EH; Rocco J; Sadow PM; Lin DT
Head Neck; 2015 Mar; 37(3):366-74. PubMed ID: 24421248
[TBL] [Abstract][Full Text] [Related]
4. Improved clinical outcomes with multi-modality therapy for sinonasal undifferentiated carcinoma of the head and neck.
Yoshida E; Aouad R; Fragoso R; Farwell DG; Gandour-Edwards R; Donald PJ; Chen AM
Am J Otolaryngol; 2013; 34(6):658-63. PubMed ID: 23993024
[TBL] [Abstract][Full Text] [Related]
5. Treatment modalities in sinonasal undifferentiated carcinoma: an analysis from the national cancer database.
Khan MN; Konuthula N; Parasher A; Genden EM; Miles BA; Govindaraj S; Iloreta AM
Int Forum Allergy Rhinol; 2017 Feb; 7(2):205-210. PubMed ID: 27717204
[TBL] [Abstract][Full Text] [Related]
6. Trimodality management of sinonasal undifferentiated carcinoma and review of the literature.
Mourad WF; Hauerstock D; Shourbaji RA; Hu KS; Culliney B; Li Z; Jacobson A; Tran T; Manolidis S; Schantz S; Urken M; Persky M; Harrison LB
Am J Clin Oncol; 2013 Dec; 36(6):584-8. PubMed ID: 22992621
[TBL] [Abstract][Full Text] [Related]
7. Outcome by treatment modality in sinonasal undifferentiated carcinoma (SNUC): A case-series, systematic review and meta-analysis.
Morand GB; Anderegg N; Vital D; Ikenberg K; Huber GF; Soyka MB; Egger M; Holzmann D
Oral Oncol; 2017 Dec; 75():28-34. PubMed ID: 29224819
[TBL] [Abstract][Full Text] [Related]
8. Sinonasal undifferentiated carcinoma (SNUC): the Alberta experience and literature review.
Xu CC; Dziegielewski PT; McGaw WT; Seikaly H
J Otolaryngol Head Neck Surg; 2013 Jan; 42(1):2. PubMed ID: 23663264
[TBL] [Abstract][Full Text] [Related]
9. A multimodality approach to sinonasal undifferentiated carcinoma: a single institute experience.
Bhasker S; Mallick S; Benson R; Bhanuprasad V; Sharma A; Thakar A
J Laryngol Otol; 2017 Jan; 131(1):19-25. PubMed ID: 27938440
[TBL] [Abstract][Full Text] [Related]
10. Minimally invasive endoscopic resection of sinonasal undifferentiated carcinoma.
Revenaugh PC; Seth R; Pavlovich JB; Knott PD; Batra PS
Am J Otolaryngol; 2011; 32(6):464-9. PubMed ID: 21041001
[TBL] [Abstract][Full Text] [Related]
11. Patterns of failure after combined-modality approaches incorporating radiotherapy for sinonasal undifferentiated carcinoma of the head and neck.
Chen AM; Daly ME; El-Sayed I; Garcia J; Lee NY; Bucci MK; Kaplan MJ
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):338-43. PubMed ID: 18207030
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of multi-modality therapies in sinonasal undifferentiated carcinoma-A timely update.
See ASY; Chu C; Lim ICZY; Tan BKJ; Ang SXQ; Xu S; Teo NWY; Charn TC
Clin Otolaryngol; 2024 Jan; 49(1):29-40. PubMed ID: 37859617
[TBL] [Abstract][Full Text] [Related]
13. Current management of sinonasal undifferentiated carcinoma.
Lopez F; Suárez V; Vivanco B; Suárez C; Llorente JL
Rhinology; 2015 Sep; 53(3):212-20. PubMed ID: 26363162
[TBL] [Abstract][Full Text] [Related]
14. Management of nonesthesioneuroblastoma sinonasal malignancies with neuroendocrine differentiation.
Fried D; Zanation AM; Huang B; Hayes N; Morris DE; Rosenman J; Varia M; Funkhouser W; Weissler M; Chera BS
Laryngoscope; 2012 Oct; 122(10):2210-5. PubMed ID: 22886723
[TBL] [Abstract][Full Text] [Related]
15. Adenoid cystic carcinoma of the paranasal sinuses: retrospective series and review of the literature.
Michel G; Joubert M; Delemazure AS; Espitalier F; Durand N; Malard O
Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Nov; 130(5):257-62. PubMed ID: 23747147
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: The importance of differentiation grade in determining treatment strategy.
van der Laan TP; Iepsma R; Witjes MJ; van der Laan BF; Plaat BE; Halmos GB
Oral Oncol; 2016 Dec; 63():1-9. PubMed ID: 27938993
[TBL] [Abstract][Full Text] [Related]
17. Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma.
Amit M; Abdelmeguid AS; Watcherporn T; Takahashi H; Tam S; Bell D; Ferrarotto R; Glisson B; Kupferman ME; Roberts DB; Su SY; Raza SM; DeMonte F; Hanna EY
J Clin Oncol; 2019 Feb; 37(6):504-512. PubMed ID: 30615549
[TBL] [Abstract][Full Text] [Related]
18. Combined-modality treatment improved outcome in sinonasal undifferentiated carcinoma: single-institutional experience of 21 patients and review of the literature.
Al-Mamgani A; van Rooij P; Mehilal R; Tans L; Levendag PC
Eur Arch Otorhinolaryngol; 2013 Jan; 270(1):293-9. PubMed ID: 22476411
[TBL] [Abstract][Full Text] [Related]
19. Survival Outcomes for Induction vs Adjuvant Chemotherapy in Squamous Cell Carcinoma of the Maxillary Sinus.
Kuo P; Torabi SJ; Kraus D; Judson BL
Otolaryngol Head Neck Surg; 2019 Apr; 160(4):658-663. PubMed ID: 30296902
[TBL] [Abstract][Full Text] [Related]
20. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
